OPKO Health (OPK) said Friday its board has authorized a $100 million increase to its share buyback program, bringing it to a total of $200 million.
About $41 million of stock has already been repurchased under the existing program, the biopharmaceutical company said.
OPKO Health said it expects to fund the repurchase program from existing cash, cash equivalents, and future cash flows.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.